Search hospitals > New York > Syracuse

Associated Medical Professionals of NY

Claim this profile
Syracuse, New York 13210
Global Leader in Prostate Cancer
Conducts research for Bladder Cancer
Conducts research for Allergy
Conducts research for Recurrence
Conducts research for Overactive Bladder
32 reported clinical trials
2 medical researchers
Photo of Associated Medical Professionals of NY in SyracusePhoto of Associated Medical Professionals of NY in SyracusePhoto of Associated Medical Professionals of NY in Syracuse

Summary

Associated Medical Professionals of NY is a medical facility located in Syracuse, New York. This center is recognized for care of Prostate Cancer, Bladder Cancer, Allergy, Recurrence, Overactive Bladder and other specialties. Associated Medical Professionals of NY is involved with conducting 32 clinical trials across 21 conditions. There are 2 research doctors associated with this hospital, such as Christopher Pieczonka, MD and Hadley Narins.

Area of expertise

1Prostate Cancer
Global Leader
Associated Medical Professionals of NY has run 22 trials for Prostate Cancer. Some of their research focus areas include:
Stage IV
PSA
Gleason Score
2Bladder Cancer
Associated Medical Professionals of NY has run 10 trials for Bladder Cancer. Some of their research focus areas include:
FGFR positive

Top PIs

Clinical Trials running at Associated Medical Professionals of NY

Bladder Cancer
Prostate Cancer
Allergy
Transitional Cell Carcinoma
Image of trial facility.

TAR-210

for Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.
Recruiting2 awards Phase 34 criteria
Image of trial facility.

Pembrolizumab + BCG

for Bladder Cancer

Researchers are looking for new ways to treat high-risk non muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread to the bladder muscle or outside of the bladder. High-risk means NMIBC may have a high chance of getting worse or coming back after treatment. The goals of this study are to learn: 1. If more people who receive pembrolizumab with Bacillus Calmette-Guerin (BCG) have no signs of cancer in their body and live longer without the cancer growing, spreading, or coming back compared to people who receive BCG alone. 2. About the safety and how well people tolerate BCG alone or in combination with pembrolizumab.
Recruiting2 awards Phase 39 criteria
Image of trial facility.

TAR-200 + Cetrelimab vs BCG

for Bladder Cancer

This trial is testing a new bladder cancer treatment using a special device to deliver a drug directly into the bladder, either alone or with an immune-boosting drug. It targets patients with high-risk bladder cancer who haven't had BCG treatment before. The device ensures a steady release of the drug, while the immune-boosting drug helps the body fight cancer.
Recruiting2 awards Phase 36 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Associated Medical Professionals of NY?
Associated Medical Professionals of NY is a medical facility located in Syracuse, New York. This center is recognized for care of Prostate Cancer, Bladder Cancer, Allergy, Recurrence, Overactive Bladder and other specialties. Associated Medical Professionals of NY is involved with conducting 32 clinical trials across 21 conditions. There are 2 research doctors associated with this hospital, such as Christopher Pieczonka, MD and Hadley Narins.